🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

15 results for “Edgewise Therapeutics” Clear

  1. EDG-5506, EDG-5506

    Edgewise Therapeutics

    Becker Muscular Dystrophy

    phase 2 small molecule active

    1 trial

  2. EDG-7500

    Edgewise Therapeutics

    Hypertrophic Cardiomyopathy

    phase 2 small molecule active

    1 trial

  3. Sevasemten

    Edgewise Therapeutics

    Becker Muscular Dystrophy

    phase 2 small molecule active

    2 trials

  4. Sevasemten 10 mg

    Edgewise Therapeutics

    Becker Muscular Dystrophy

    phase 2 small molecule active

    1 trial

  5. Sevasemten Dose 1

    Edgewise Therapeutics

    Duchenne Muscular Dystrophy

    phase 2 small molecule active

    2 trials

  6. EDG-15400

    Edgewise Therapeutics

    Healthy Adults

    phase 1 small molecule active

    1 trial

  7. EDG-5506

    Edgewise Therapeutics

    Muscular Dystrophies

    phase 1 small molecule completed

    1 trial

  8. EDG-5506

    Edgewise Therapeutics

    Healthy Volunteer

    phase 1 small molecule completed

    1 trial

  9. EDG-5506 Tablet

    Edgewise Therapeutics

    Healthy Volunteer

    phase 1 small molecule completed

    1 trial

  10. EDG-7500

    Edgewise Therapeutics

    Healthy Subjects

    phase 1 small molecule completed

    1 trial

  11. EDG-7500

    Edgewise Therapeutics

    Healthy Adult Participants

    phase 1 small molecule active

    1 trial

  12. EDG-7500

    Edgewise Therapeutics

    Hepatic Impairment (HI)

    phase 1 small molecule active

    1 trial

  13. EDG-7500

    Edgewise Therapeutics

    Renal Impairments

    phase 1 small molecule completed

    1 trial

  14. [14C]-EDG-7500

    Edgewise Therapeutics

    Healthy Volunteer

    phase 1 small molecule completed

    1 trial

  15. sevasemten

    Edgewise Therapeutics

    Healthy Subjects

    phase 1 small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources